Triparna Sen: Pulmonary Neuroendocrine Neoplasms – a hard-to-treat cancer type with a pressing need for better strategies
Triparna Sen, Associate Professor at Icahn School of Medicine at Mount Sinai, shared a recent article on LinkedIn:
“Thrilled to announce our review article in Lancet Oncology on Pulmonary Neuroendocrine Neoplasms – a hard-to-treat cancer type with a pressing need for better strategies.
This comprehensive review covers:
- Molecular Landscape.
- Therapeutic challenges.
- Diagnosis and management strategies.
Kickstarting 2025 with teamwork and dedication to advancing care for LungNETs.
- Honored to collaborate with an exceptional team, including SWOG investigators- Dr. Nagla Karim Fred, Hirsch Vineeth, Sukrithan, Raid Aljumaily, and others.
- Thankful to the Lancet Oncology editorial team for a fantastic publication experience.
Let’s tackle these complex diseases with precision, not borrowed solutions.”
Authors: Triparna Sen, Yosuke Dotsu, Virginia Corbett, Sonam Puri, Utsav Se Theresa A Boyle, Phil Mack, Fred Hirsch, Raid Aljumaily, Abdul Rafeh Naqash, Vineeth Sukrithan and Nagla Abdel Karim
Dr. Triparna Sen is an Associate Professor, in the Department of Oncological Sciences, and the Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. She leads a multi-disciplinary team of investigators in laboratory-based, patient-focused investigations focused on cancer biology and precision medicine.
More posts featuring Triparna Sen.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023